Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03403257 · ClinicalTrials.gov registry record

Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)

A clinical trial of Dementia and Dementia, Vascular, sponsored by University of Michigan.

Active
Registry status
634
Enrollment target
1
Study location

NCT03403257 is a study of Dementia and Dementia, Vascular that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 634 participants, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03403257, a study of Dementia and Dementia, Vascular, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
634 participants
Enrollment target
1
Study location

Study Summary

The Mexican American population in the U.S. is rapidly growing and aging. This project seeks to determine the prevalence and outcomes of cognitive impairment and dementia in Mexican Americans. It also seeks solutions to help patients with cognitive impairment and dementia and their caregivers get the resources they need.

Interventions

  • OTHER No interventions

Study Locations (1)

Texas

  • Corpus Christi Nueces County Health District - Corpus Christi

Trial Details

FieldValue
Enrollment Target 634 participants
Start Date 2018-04-11
Est. Completion 2027-04-30

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03403257

The ClinicalTrials.gov registry entry for NCT03403257 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 634 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which No interventions is the first listed.

NCT03403257 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03403257 about?

NCT03403257 is a clinical study titled "Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)". The Mexican American population in the U.S. is rapidly growing and aging. This project seeks to determine the prevalence and outcomes of cognitive impairment and dementia in Mexican Americans. It also seeks solutions to help patients with cognitive impairment and dementia and their caregivers get th...

What is the current status of trial NCT03403257?

This trial is currently active not recruiting. The enrollment target is 634 participants. The study started on 2018-04-11. Estimated completion is 2027-04-30.

What conditions does trial NCT03403257 study?

This clinical trial studies the following conditions: Dementia, Dementia, Vascular, Dementia Alzheimers, Dementia, Mixed.

What interventions are being tested in trial NCT03403257?

The interventions under investigation include: No interventions (OTHER).

Who is sponsoring clinical trial NCT03403257?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03403257 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.